Hierarchical integration of DNA nanostructures and NanoGold onto a microchip facilitates covalent chemistry-mediated purification of circulating tumor cells in head and neck squamous cell carcinoma. (April 2023)

• Record Type: Journal Article
• Authors: Sun, Na; Zhang, Ceng; Wang, Jing; Yue, Xinmin; Kim, Hyo Yong; Zhang, Ryan Y.; Liu, Hongtao; Widjaja, Josephine; Tang, Hubert; Zhang, Tiffany X.; Ye, Jinglei; Qian, Audrey; Liu, Chensong; Wu, Alex; Wang, Katharina; Johanis, Michael; Yang, Peng; Liu, Honggang; Meng, Meng; Liang, Li; Pei, Renjun; Chai-Ho, Wanxing; Zhu, Yazhen; Tseng, Hsian-Rong
• Is Part Of: Nano today. Volume 49(2023)
• Publication Date: 2023-04
• Subjects: NanoGold -- Tetrahedral DNA nanostructure -- Covalent chemistry -- Circulating tumor cell -- Head and neck squamous cell carcinoma; Nanotechnology -- Periodicals; Nanosciences -- Périodiques; 620.505
• DOI: 10.1016/j.nantod.2023.101786
• Languages: English
• ISSNs: 1748-0132

Abstract

Abstract: It is well-established that the combined use of nanostructured substrates and immunoaffinity agents can enhance the cell-capture performance of the substrates, thus offering a practical solution to effectively capture circulating tumor cells (CTCs) in peripheral blood. Developing along this strategy, this study first demonstrated a top-down approach for the fabrication of tetrahedral DNA nanostructure (TDN)-NanoGold substrates through the hierarchical integration of three functional constituents at various length-scales: a macroscale glass slide, sub-microscale self-organized NanoGold, and nanoscale self-assembled TDN. The TDN-NanoGold substrates were then assembled with microfluidic chaotic mixers to give TDN-NanoGold Click Chips. In conjunction with the use of copper (Cu)-catalyzed azide-alkyne cycloaddition (CuAAC)-mediated CTC capture and restriction enzyme-triggered CTC release, TDN-NanoGold Click Chips allow for effective enumeration and purification of CTCs with intact cell morphologies and preserved molecular integrity. To evaluate the clinical utility of TDN-NanoGold Click Chips, we used these devices to isolate and purify CTCs from patients with human papillomavirus (HPV)-positive (+) head and neck squamous cell carcinoma (HNSCC). The purified HPV(+) HNSCC CTCs were then subjected to RT-ddPCR testing, allowing for detection of E6/E7 oncogenes, the characteristic molecular signatures of HPV(+) HNSCC. We found that the resulting HPV(+) HNSCC CTC counts and E6/E7 transcript copy numbers are correlated with the treatment responses in the patients, suggesting the potential clinical utility of TDN-NanoGold Click Chips for noninvasive diagnostic applications of HPV(+) HNSCC. Graphical Abstract: ga1 Highlights: Construction of tetrahedral DNA nanostructure-NanoGold substrate for purifying CTCs. TDN-NanoGold Click Chip combined CuAAC and restriction enzyme for CTC purification. HPV E6/E7 oncogenes were detected in CTCs purified from HPV(+) HNSCC patients. TDN-NanoGold Click Chip can be used for noninvasive diagnosis of HPV(+) HNSCC.